Close
American Drug Delivery & Formulation Summit
Xylem

Press Releases

Shilpa Biologicals Launches PartnerPower Platform for CDMOs

Shilpa Biologicals Pvt. Ltd. (SBPL) has introduced PartnerPower Platform, a proprietary digital transparency solution designed to provide global sponsors with continuous, real-time visibility across biologics development and manufacturing activities. Announced on 22 June 2026 from Dharwad, India, the platform...

Alcami Strengthens Tennessee Facility with Quality, Packaging and Storage Capacity

Alcami Corporation has announced a series of strategic investments at its Tennessee facility, a site that recently became part of the companyโ€™s network through the acquisition of Tjoapack. The initiative is aimed at strengthening operations across quality, packaging, storage,...

MGS Advances Healthcare Product Development with Hybrid Tooling

MGS, a healthcare-focused contract development and manufacturing organization, has expanded its Hybrid Tooling capability worldwide after successfully deploying the approach alongside its A.i.r. Platformโ„ข. The company said the broader rollout is intended to help healthcare manufacturers accelerate product development,...

Aptar Advances Pharmaceutical Packaging as N-Sorb Technology Gains Patent Approval

Aptar Active Material Science, a division of AptarGroup, Inc., has reached an important intellectual property milestone after receiving approval from the United States Patent and Trademark Office (USPTO) for its foundational U.S. patent application covering N-Sorb Technology. Announced on...

CPHI Americas Relocates to Miami to Strengthen Global Industry Connectivity

Informa Markets has announced that CPHI Americas will relocate to Miami in 2027, marking a significant step in the eventโ€™s ongoing development as a platform for pharmaceutical innovation, outsourcing and strategic partnerships. Scheduled for May 25-26, 2027, at the...

Aragen Achieves Daretabart Commercial-scale GMP Production

Aragen, a global leader in Contract Research, Development, and Manufacturing Organization (CRDMO) services, has announced the successful technology transfer and commercial-scale GMP manufacturing of the first batches of Daretabart, Renaissance Pharmaโ€™s lead therapeutic candidate for high-risk neuroblastoma. The milestone...

Nestlรฉ and IdB Partner to Bring rCDI Preventive Therapy to Europe

Nestlรฉ Health Science and IdB Holding have officially announced a VOWST licensing agreement to develop and commercialize the oral therapy in Europe, subject to approval by the European Medicines Agency (EMA). This collaboration aims to expand European patient access...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป